Stockscreener 앱 받기
15.22
0.85%
-0.13
시간 외 거래:
15.26
0.04
+0.26%
전일 마감가:
$15.35
열려 있는:
$15.47
하루 거래량:
1.06M
Relative Volume:
0.74
시가총액:
$1.96B
수익:
$298.30M
순이익/손실:
$298.21M
주가수익비율:
7.0342
EPS:
2.1637
순현금흐름:
$166.93M
1주 성능:
-0.20%
1개월 성능:
-11.67%
6개월 성능:
+4.46%
1년 성능:
+70.44%
1일 변동 폭
$15.20
$15.77
1주일 범위
$15.01
$15.77
52주 변동 폭
$8.80
$19.25
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
명칭
Aurinia Pharmaceuticals Inc
전화
250-744-2487
주소
#140, 14315 - 118 AVENUE, EDMONTON, BC
Compare AUPH vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
15.22 | 1.97B | 298.30M | 298.21M | 166.93M | 2.1637 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-03 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-11-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-11-05 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-07-30 | 재개 | H.C. Wainwright | Buy |
| 2022-11-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-05-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-12-10 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-01-25 | 재확인 | H.C. Wainwright | Buy |
| 2020-11-03 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-05-05 | 개시 | Cowen | Outperform |
| 2020-01-10 | 개시 | Jefferies | Buy |
| 2019-12-16 | 재확인 | H.C. Wainwright | Buy |
| 2018-03-16 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-02-08 | 개시 | RBC Capital Mkts | Outperform |
| 2017-10-30 | 재확인 | H.C. Wainwright | Buy |
| 2017-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2017-04-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-03-22 | 재확인 | FBR & Co. | Outperform |
| 2016-12-30 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-17 | 재확인 | H.C. Wainwright | Buy |
| 2016-06-30 | 개시 | H.C. Wainwright | Buy |
| 2015-05-08 | 개시 | MLV & Co | Buy |
모두보기
Aurinia Pharmaceuticals Inc 주식(AUPH)의 최신 뉴스
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a shareEarnings Preview - TradingView
Aurinia Pharmaceuticals Inc (AUPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aurinia Pharmaceuticals Inc (AUPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aurinia Pharmaceuticals Inc (AUPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aurinia Pharmaceuticals Inc. Revenue Breakdown – LS:A1W7D4 - TradingView
AUPH|Aurinia Pharmaceuticals Inc|Price:15.350|Chg%:+0.110 - TradingKey
AUPH|Aurinia Pharmaceuticals Inc|Price:15.400|Chg%:+0.160 - TradingKey
TradingKey - TradingKey
AUPH Q2'26 Earnings: revenue estimate is 80.45M USD - TradingView
Liquidity Mapping Around (AUPH) Price Events - Stock Traders Daily
Aurinia Pharmaceuticals Inc (AUPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aurinia Pharmaceuticals Inc (AUPH) Earnings, Actual EPS, EPS Estimates & Results - Stocktwits
Aurinia Pharmaceuticals Inc (AUPH) Fundamental & Financial Data - Stocktwits
Aurinia Pharmaceuticals (AUPH) Q1 2026 earnings summary - Quartr
Aurinia Pharmaceuticals (AUPH) Proxy filing Summary - Quartr
Aurinia Pharmaceuticals (AUPH) Proxy Filing Summary - Quartr
Aurinia Pharmaceuticals (AUPH) 2024 Cantor Fitzgerald Global Healthcare Conference summary - Quartr
Aurinia Pharmaceuticals (AUPH) Q4 2024 earnings summary - Quartr
Aurinia Pharmaceuticals (AUPH) Q4 2025 earnings summary - Quartr
Aurinia Pharmaceuticals (AUPH) Jefferies 2024 Global Healthcare Conference Summary - Quartr
Investors - Aurinia Pharmaceuticals Inc.
AUPH Stock Sees Biggest Single-Day Drop In More Than 9 Months Despite Q1 Earnings Beat – Here’s What’s Spooking Investors - Stocktwits
bullish divergence on the hourly has held above support at 15.50, i like the stock 😀 - Moomoo
Price to earnings forward of Aurinia Pharmaceuticals Inc. – SWB:IKAP - TradingView
Is Aurinia Pharmaceuticals (AUPH) Using Combination LN Trials to Redefine Its LUPKYNIS Strategy? - Sahm
Price to earnings forward of Aurinia Pharmaceuticals Inc. – MUN:IKAP - TradingView
AUPH Stock Price and Chart — NASDAQ:AUPH - TradingView
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis - BioSpace
TD Cowen Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Maintains Target Price $17 - Moomoo
Aurinia Unchanged on Unveiling Lupus Treatment - Baystreet.ca
Aurinia launches trial combining lupus nephritis treatments - Investing.com
Aurinia Pharmaceuticals Initiates Phase 4 PRESERVE Study in Lupus Nephritis Combination Therapy - Moomoo
Aurinia launches trial combining lupus nephritis treatments By Investing.com - Investing.com South Africa
Aurinia Pharmaceuticals balances autoimmune drug focus and U.S. market ambitions - Ad-hoc-news.de
Enterprise value to EBITDA forward of Aurinia Pharmaceuticals Inc – NASDAQ:AUPH - TradingView
AUPHAurinia Pharmaceuticals Inc Latest SEC Filings - Finviz
Document - SEC.gov
Aurinia (AUPH) Upgraded to Strong Buy: Here's Why - Yahoo Finance
If EPS Growth Is Important To You, Aurinia Pharmaceuticals (NASDAQ:AUPH) Presents An Opportunity - Moomoo
Why (AUPH) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now? - Insider Monkey
IKAP Forecast — Price Target — Prediction for 2027 - TradingView
Aurinia Pharmaceuticals Inc (AUPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to sales forward of Aurinia Pharmaceuticals Inc – NASDAQ:AUPH - TradingView
Aurinia Pharmaceuticals Inc. Actuals & Estimates (NASDAQ:AUPH) - TradingView
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail
Enterprise value to EBIT forward of Aurinia Pharmaceuticals Inc – NASDAQ:AUPH - TradingView
Price to earnings forward of Aurinia Pharmaceuticals Inc. – LSX:A1W7D4 - TradingView
Aurinia Pharmaceuticals Inc. Actuals & Estimates (SWB:IKAP) - TradingView
AUPH Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Aurinia Pharmaceuticals Inc – NASDAQ:AUPH - TradingView
Aurinia Pharmaceuticals Inc (AUPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.97%
0.83%
자본화:
|
볼륨(24시간):